Bing Zhou

Title: Innovations of Inventor Bing Zhou

Introduction

Bing Zhou is a notable inventor based in Yantai, China, recognized for his contributions to biotechnology. He holds two patents that showcase his innovative work in the field, particularly focusing on therapeutic proteins and their applications in treating diseases.

Latest Patents

One of his latest patents is the "Therapeutic TRAIL fusion protein and preparation and use thereof." This invention provides a TRAIL chimeric protein, along with the DNA sequence encoding it, vectors, host cells, and transgenic animals that contain these vectors. The chimeric protein features a human leucine zipper sequence and human TRAIL protein, which significantly enhances its stability and efficacy, making it a promising candidate for future applications.

Another significant patent is the "N-terminal modified recombinant human endostatin and its production." This invention focuses on rhEndostatin proteins that include an additional metal chelating peptide sequence at the N-terminal. It details methods for modifying rhEndostatin to improve its stability and biological activity, particularly in treating angiogenesis-related diseases, including tumors.

Career Highlights

Bing Zhou has worked with several companies, including Yantai Medgenn Ltd. and Magellan Pharma Co. Ltd. His experience in these organizations has contributed to his expertise in biotechnology and the development of innovative therapeutic solutions.

Collaborations

He has collaborated with notable coworkers such as Yongzhang Luo and Zhuobing Zhang, further enhancing his research and development efforts in the field.

Conclusion

Bing Zhou's innovative work in biotechnology, particularly through his patents, demonstrates his significant contributions to the field. His inventions have the potential to impact the treatment of various diseases, showcasing the importance of research and development in advancing medical science.